GlassScriptPhysician profile
Angelo S Ferraro
NPI 1740236405
$3,914.27
in general payments reported to CMS, 2019-2025
18 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $287 · 2021: $271 · 2022: $33.00 · 2023: $1,820 · 2024: $691 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Travel and Lodging: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,926.66 |
| Travel and Lodging | $886.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,034.82 | 2019-2023 | Optis, Dragonfly Opstar |
| Boston Scientific Corporation | $396.37 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $302.13 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.75 | 2019-2024 | Jardiance |
| Abiomed | $176.70 | 2019-2020 | |
| Amgen INC. | $155.67 | 2021-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $148.95 | 2019-2025 | |
| Medtronic, INC. | $132.20 | 2021 | |
| Janssen Pharmaceuticals, INC | $67.82 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $67.73 | 2020-2025 | Farxiga |
| Chiesi USA, INC. | $40.41 | 2023-2024 | Kengreal, Cleviprex |
| Novo Nordisk INC | $34.66 | 2024-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $30.85 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $23.79 | 2025 | Camzyos |
| Merck Sharp & Dohme LLC | $19.80 | 2024 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $18.85 | 2023 | Gore Excluder Iliac Branch Endoprosthesis |
| Philips North America LLC | $13.47 | 2025 | Mcot |
| Shockwave Medical, INC | $13.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Ferraro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.